note ||| THE JOURNAL OF BIOLOGICAL CHEMISTRY |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
note ||| Vol. 249, No. 7, Issue of April 10, pp. 2098-2104, 1974 |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
note ||| Printed in U.S.A. |XML| xmlLoc_0 xmlBold_no xmlItalic_yes xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_continue
title ||| Glycosphingolipid 13-Galactosidases |XML| xmlLoc_0 xmlBold_yes xmlItalic_no xmlFontSize_largest0 xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
title ||| I. STANDARD ASSAY PROCEDURES AND CHARACTERIZATION BY ELECTROFOCUSING AND GEL |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
title ||| FILTRATION OF THE ENZYMES IN NORMAL HUMAN LIVER* |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
note ||| (Received for publication, September 21, 1973) |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
author ||| YOSHIYUKI SUZUKII AND KUNIHIKO SUZUKI� |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
affiliation ||| From the Saul R. Korey Department of Neurology and the Rose F. Kennedy Center for Research in Mental Re- |XML| xmlLoc_1 xmlBold_no xmlItalic_yes xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
affiliation ||| tardation and Human Development, Albert Einstein College of Medicine, Bronx, New York 10461, and the De- |XML| xmlLoc_1 xmlBold_no xmlItalic_yes xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
affiliation ||| partment of Neurology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104 |XML| xmlLoc_2 xmlBold_no xmlItalic_yes xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
sectionHeader ||| SUMMARY |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
bodyText ||| Specific glycosphingolipid 0-galactosidases in normal |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
bodyText ||| human liver were investigated using radioactively labeled |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| galactosylceramide, lactosylceramide, Gml-ganglioside, and |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| asialo GM!-ganglioside as substrates. Chloride ion was re- |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| quired for full stimulation and stabilization of these reac- |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| tions. Taurocholate was the most effective stimulator, ex- |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| cept for Gmi-ganglioside 0-galactosidase which did not ap- |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| pear to be affected by any of the detergents tested. Elec- |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| trofocusing of the 10,000 X g supernatant of sonicated, |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| frozen-thawed water homogenates gave three consistent |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| peaks of nonspecific 4-methylumbelliferyl 0-galactosidase |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| activities. Their isoelectric points were pH 4.1 to 4.2 (a), |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| 4.5 to 4.6 (#), and 4.8 to 4.9 (7). All of the three peaks con- |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| tained activities of lactosylceramide and asialo Gmi-ganglio- |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| side 13-galactosidases, but the activities of galactosylceramide |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| and GM!-ganglioside 13-galactosidases were present only in |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| the 13 and 7 peaks. Gel filtration with Sephadex G-200 |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| separated activities of 4-methylumbelliferyl 0-galactosidase |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| into three peaks. When each of the gel filtration peaks was |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| subjected to electrofocusing, the second gel filtration peak |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| corresponded to the # peak, and the third peak to the 7 peak, |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| respectively. The first gel filtration peak, however, gave |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| inconsistent results in electrofocusing, always giving a single |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| peak but with varying isoelectric points. The primary |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| purpose of this study was to establish the optimal assay condi- |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| tions for these enzymes in whole tissues and to obtain a |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| reproducible fractionation procedure, without sacrificing the |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| recovery of total activities. These were the criteria neces- |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| sary for the subsequent studies of disorders in which specific |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| glycosphingolipid 0-galactosidases are genetically deficient. |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
note ||| * This investigation was supported by Research Grants NS- |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
note ||| 08420, NS-10885, NS-03356, and HD-01799 from the United States |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
note ||| Public Health Service and by Grant 670-B-2 from the National |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
note ||| Multiple Sclerosis Society. |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
affiliation ||| Present address, Department of Pediatrics, University of |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
affiliation ||| Tokyo, Faculty of Medicine, Tokyo, Japan. |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
affiliation ||| � To whom correspondence should be sent at the Rose F. Ken- |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
affiliation ||| nedy Center for Research in Mental Retardation and Human |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
affiliation ||| Development, Albert Einstein College of Medicine, Bronx, N. Y. |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
affiliation ||| 10461. |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| All sphingolipid storage disorders are caused by genetic defi- |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
bodyText ||| ciency of specific sphingolipid hydrolases. The present state of |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| knowledge in the field is reviewed extensively in a recent mono- |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| graph (1). With a few exceptions, such as sphingomyelinase in |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| Niemann-Pick disease, arylsulfatase A in metachromatic leuko- |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| dystrophy, and ceramidase in Farber's lipogranulomatosis, the |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| enzymes involved in this group of genetic disorders are sphingo- |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| lipid glycosidases which normally cleave the terminal carbohy- |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| drate moieties of respective glycosphingolipids. Some of these |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| defects are highly specific in that natural lipid substrates appear |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| to be required to demonstrate the defects, such as in globoid cell |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| leukodystrophy (2) or lactosylceramide lipidosis (3). While arti- |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| ficial substrates such as p-nitrophenyl or 4-methylumbelliferyl |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| derivatives can demonstrate the enzymatic defects in other dis- |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| eases, e.g. Fabry's disease (4), Gm i-gangliosidosis (5), Gmz- |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| gangliosidosis (6-8), and metachromatic leukodystrophy (9), the |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| use of natural substrates is highly desirable to investigate the |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| nature of the deficient mutant enzymes in these disorders. The |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| present series of investigations is aimed at preliminary charac- |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| terization of sphingolipid 13-galactosidases in normal human liver |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| with the use of specifically labeled natural substrates, which will |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| then serve as the basis for the subsequent studies of these enzymes |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| in livers of patients with genetic deficiencies of specific sphingo- |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| lipid glycosidases. |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
sectionHeader ||| MATERIALS AND METHODS |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
subsectionHeader ||| Isotopically Labeled Natural Substrates |XML| xmlLoc_5 xmlBold_no xmlItalic_yes xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
bodyText ||| Glycosphingolipids used for this study were galactosylceramide, |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
bodyText ||| lactosylceramide, GM i-ganglioside (galactosyl-N-acetylgalactosa- |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| minyl4N-acetylneuraminyllgalactosyl-glucosylceramide) and asi- |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| alo Gm j-ganglioside (galactosyl-N-acetylgalactosaminyl-galac- |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| tosyl-glucosylceramide). All of these compounds have a terminal |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_continue
bodyText ||| 0-galactosyl moiety. Bovine brain galactosylceramide was a |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_continue
bodyText ||| commercial product. Crude Gm 1-ganglioside was obtained from |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| brain tissue of a patient with Gml-gangliosidosis by the standard |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| chloroform-methanol (2:1, v/v) extraction, partition of the ex- |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| tract with the addition of 0.2 volume of water, and dialysis of the |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| upper methanol-water phase (10). To obtain lactosylceramide |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| and asialo GM!-ganglioside, a crude mixture of bovine brain gan- |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| glioside was partially hydrolyzed in 0.1 N HC1 at 100� for 60 min. |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| Five volumes of chloroform-methanol (2:1, v/v) were added, and |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| the lower chloroform phase was dried. The products of the partial |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| acid hydrolysis consisted mainly of lactosylceramide and asialo |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| Gml-ganglioside, which were subsequently fractionated and puri- |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| fied by silicic acid column chromatography (11). |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
page ||| 2098 |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
page ||| 2099 |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
bodyText ||| The tritium label was introduced to C-6 of the galactose moiety |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
bodyText ||| of these compounds by the sequential galactose oxidase and so- |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| dium [311Thorohydride reduction method. Galactosylceramide |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| and lactosylceramide were labeled as originally described by |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| Radin and co-workers (12, 13). The final purification of the la- |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| beled galactosylceramide and lactosylceramide was by silicic acid |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| column chromatography as we utilized previously (11). Asialo |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| Gm i-ganglioside was labeled with a procedure identical as above, |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| but the final purification of the labeled product was the prepara- |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| tive Silica Gel G thin layer chromatography in a solvent system |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| of chloroform-methanol-water (70:30:4, by volume) (14). Trit- |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| ium labeling of Gm i-ganglioside required some modifications of |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| the above procedure dictated by the preferential water solubility |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| of ganglioside. The modified procedure was identical with that |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| which we recently described for Gm2-ganglioside (15), except that |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| the pretreatment with unlabeled sodium borohydride was unneces- |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| sary. The final labeled Gml-ganglioside was purified by prepara- |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| tive thin layer chromatography in the solvent system of chloro- |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| form-methanol-2.5 N ammonia (60:40:9, by volume). |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| Each of the final radioactive products was subjected to thin |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
bodyText ||| layer chromatography in two solvent systems; chloroform-metha- |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| nol-H20 (70:30:4, by volume) and chloroform-methanol-concen- |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| trated ammonia (70:30:5, by volume) for the hexosylceramides, |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| and chloroform-methanol-2.5 N ammonia (60:40:9, by volume) and |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| 1-propanol-H20 (7:3, v/v) for Gm i-ganglioside. All of the com- |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| pounds gave single spots by thin layer chromatography. At least |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| 95% of the radioactivity applied to the thin layer plates was re- |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| covered from the areas of the respective compounds in all in- |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| stances. Acid hydrolysis and paper chromatography (15) indi- |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| cated that at least 85 to 95% of the radioactivity was localized in |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| the galactose moiety within the respective labeled compounds. |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| The specific activities of the final compounds (counts per min per |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| nmole) were 50,000 for galactosylceramide, 7,400 for lactosylcer- |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| amide, 14,000 for Gm 1-ganglioside and 9,400 for asialo Gm i-gan- |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| glioside. Galactosylceramide was diluted with nonradioactive |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| galactosylceramide to a specific activity of 5,000 cpm per nmole |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| for subsequent studies. All other labeled substrates were used |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| without dilution. |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| Radioactivity was determined with a Packard 3320 scintillation |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
bodyText ||| counter in a system containing 0.5 ml of water and 12 ml of toluene- |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| based scintillation solvent. The solvent contained 7 g of PPO |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| (2,5-diphenyloxazole), 0.6 g of dimethyl-POPOP (1, 4-bis[2-(4- |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| methy1-5-phenyloxazolyMbenzene), and 100 ml of Bio-Solv BBS-3 |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| in 1 liter of toluene. |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
subsectionHeader ||| Enzyme Source |XML| xmlLoc_4 xmlBold_no xmlItalic_yes xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
bodyText ||| All specimens used for this investigation were postmortem hu- |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
bodyText ||| man livers without clinical or pathological abnormalities. They |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| were stored at —30°. The tissue was weighed and homogenized |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| in 9 volumes of water (w/v) in a hand-operated Dounce homoge- |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| nizer (Kontes Glass, Vineland, N. J.), first with several strokes |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| with the loose Pestle A and then with 10 strokes with Pestle B, |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| ultrasonically disrupted for 1 min in a water bath type ultrasoni- |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| cator, and then centrifuged at 1000 X g for 10 min. This low |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| speed supernatant was used as the enzyme source either without |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| dilution (for galactosylceramide and Gmi-ganglioside 0-galactosid- |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| ases) or after appropriate dilutions (for lactosylceramide and |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| asialo Gml-ganglioside 0-galactosidases). |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
subsectionHeader ||| Standard Assay System |XML| xmlLoc_6 xmlBold_no xmlItalic_yes xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
bodyText ||| Galactosylceramide 0-Galactosidase—The standard system was a |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
bodyText ||| direct adaptation of the assay system by Bowen and Radin (16), |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| established as the result of their extensive investigation of the |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| enzyme in rat brain (16-18). We had previously demonstrated |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| the adaptability of this system for assays of the enzyme in human |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| liver (2, 19). The system consisted of 0.2 ml of the enzyme source, |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| 100 ihg of labeled substrate, 1 mg of Tween 20, 0.5 mg of Myrj 59 |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| (polyoxyethylene stearate), and 2 mg of sodium taurocholate, all |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| suspended in 0.4 ml of water, 0.1 ml of "activator suspension" |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| containing 0.35 mg of oleic acid and 0.165 mg of Tris base, 0.2 ml |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| of Buffer A (50 mm Tris-HC1, 10 mm MgCl2, and 8 mm mercapto- |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| ethanol) (16) diluted with 2 parts of water, and 0.1 ml of 1 M sodium |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| citrate buffer, pH 4.5. Incubation was at 37� for 2 to 3 hours. |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| Lactosylceramide O-Galactosidase—The incubation mixture con- |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| sisted of 0.2 ml of 0.2 m sodium citrate buffer (pH 4.8) containing |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| 20 mm NaC1, 0.1 ml of the enzyme source, and 0.1 ml of sodium |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| taurocholate (10 mg per ml) in which 50 gg of the labeled substrate |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| were suspended. Incubation was carried out at 37� for 60 to 120 |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
bodyText ||| min. |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| Asialo Gml-Ganglioside O-Galactosidase—The standard assay |XML| xmlLoc_0 xmlBold_no xmlItalic_yes xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
bodyText ||| system was identical with that for lactosylceramide 0-galactosid- |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_continue
bodyText ||| ase, except labeled lactosylceramide was replaced by 50 ag of |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| labeled asialo Gm 1-ganglioside. As discussed below, this enzyme |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| was the least stable among the four lipid j3-galactosidases, the |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| reaction was linear only up to 1 hour, and incubation was routinely |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| terminated either at 30 or 60 min. |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| G Afj-Ganglioside 0-Galactosidase—The incubation mixture con- |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
bodyText ||| sisted of 0.1 ml of 0.2 m citrate buffer (pH 4.4) containing 20 II1M |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| NaCl, 0.1 ml of the enzyme source, and 5 l of water solution con- |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| taining 50 ag of the labeled substrate. Incubation was at 37� for |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| 60 min. |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| For all of the above reactions, the final pH was within �0.1 pH |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
bodyText ||| unit of the buffers used, and the amounts of the enzyme source |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| were within the linear range of the reactions. |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
subsectionHeader ||| Determination of Liberated Galactose |XML| xmlLoc_2 xmlBold_no xmlItalic_yes xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
bodyText ||| At the end of incubation, the reaction was stopped by adding 5 |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
bodyText ||| ml of chloroform-methanol (2:1, v/v) and 0.1 ml of unlabeled |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| galactose solution (1 mg per ml) as a carrier. An appropriate |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| volume of water also was added to make the total volume of water |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| in the tube 1.0 ml. Galactosylceramide, lactosylceramide and |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| asialo Gm i-ganglioside partitioned into the lower chloroform phase |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| while liberated galactose remained in the upper methanol-water |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| phase. The unaltered labeled substrates were eliminated by re- |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| moving the lower phase. The upper phase was washed twice with |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| the addition of 2.0 ml of chloroform. Aliquots of the final upper |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| phase were dried in scintillation vials and the radioactivity was |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| determined as described above. Sample activities were corrected |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| for blank tube activities. For the determination of galactose |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| liberated from Gm i-ganglioside, the above procedure was modified |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| because the substrate also partitions into the upper phase. The |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| entire upper phase was applied on a Silica Gel G thin layer plate |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| as a 6- to 8-cm long streak and was subjected to thin layer chro- |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| matography in 1-propanol-water (20:1, v/v). Standard galactose |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| was run at one end of the plate. This solvent system completely |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| separated free galactose (I? = 0.5) from Gm i-ganglioside which |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| was essentially immobile. The standard galactose spot was visu- |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| alized by exposing the plate to iodine vapor. The area corre- |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| sponding to standard galactose was scraped into a counting vial. |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| The vial was lightly filled with thixotropic gel powder (Cab-O-Sil), |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| 12 ml of a toluene-based scintillation solvent were added, and |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| radioactivity was determined. The blank samples were carried |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| through the entire procedure and were used to correct the sample |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| counts. Preliminary experiments indicated that the counting |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| efficiency of tritium was reduced to 51 to 52% of the counts ob- |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| tained without silica gel and Cab-O-Sil in the vial. However, |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| fluctuations in the amounts of silica gel and Cab-O-Sil were not |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| critical for the counting efficiency. |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
subsectionHeader ||| Nonspecific 13-Galactosidase |XML| xmlLoc_5 xmlBold_no xmlItalic_yes xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
bodyText ||| 4-Methylumbelliferyl 0-Galactosidase—Nonspecific ,8-galactosid- |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
bodyText ||| ase, as measured with 4-methylumbelliferyl (3-galactoside as the |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| substrate, was included as a reference enzyme. The incubation |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| system contained 0.1 ml of the enzyme source and 0.3 ml of 0.1 m |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| sodium citrate buffer (pH 5.0) containing 1 mm substrate. The |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| mixture was incubated at 37� for 15 to 60 min and the reaction was |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| stopped by the addition of 2 ml of 0.2 m glycine buffer (pH 10.7). |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| Liberated 4-methylumbelliferone was determined spectrofluoro- |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| metrically with an excitation wavelength of 365 nm and an emis- |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| sion wavelength of 448 nm. |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
subsectionHeader ||| Enzyme Fractionation |XML| xmlLoc_6 xmlBold_no xmlItalic_yes xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
bodyText ||| Electrofocusing—Liver tissue (1 g) was homogenized in 9 ml of |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
bodyText ||| distilled water in a Potter-Elvehjem homogenizer with a Teflon |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| pestle, sonicated for 1 min in a water bath-type ultrasonicator, and |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| centrifuged at 10,000 X g for 10 min. This supernatant was used |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| as the starting material for fractionation. Electrofocusing was |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| carried out in a small column (110-ml capacity, LKB No. 8101) |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| with a linear sucrose gradient solution containing 1% ampholyte, |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| pH range 4 to 6. The concentration of the sucrose gradient was |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| from 66 to 0%. The sample was mixed with one of the two solu- |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| tions at the time of the gradient formation and was thus evenly |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| dispersed in the column prior to the application of the electric |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
figure ||| t • 4 |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
figure ||| •	3 |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
figure ||| •	2 |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
figure ||| 8 |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
figure ||| 5 |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
figure ||| 0 |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
figure ||| 120 |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
figure ||| 60 |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
figure ||| INCUBATION TIME, min. |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
figure ||| 2100 |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
figure ||| 0.• |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
figure ||| 52 |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
figure ||| x 7 — |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
figure ||| 6 — |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
figure ||| Ci |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
figure ||| 5 |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
figure ||| F. |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
figure ||| 120	0 |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
figure ||| 30	60	120 |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
figure ||| INCUBATION TIME, min. |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
figure ||| LU |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
figure ||| IY 3 |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
figure ||| 0_ 2 |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
figure ||| g0 |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
figure ||| 30	60 |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
figure ||| INCUBATION TIME, min. |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
figure ||| .7 |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
figure ||| // |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
figureCaption ||| FIG. 1. The effect of chloride ion on the time course of the reac- |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
figureCaption ||| tions. A, lactosylceramide 0-galactosidase ; B, asialo Cm 1-gan- |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_continue
figureCaption ||| glioside 0-galactosidase; and C, Gm i-ganglioside O-galactosidase. |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
figureCaption ||| The assays were carried out according to the standard procedures |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
figureCaption ||| described in the text, except that • • represents the results |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_continue
bodyText ||| current. The top electrode was the cathode. The current was |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
bodyText ||| applied for 24 hours with the initial voltage of 300 volts which |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| was gradually increased during the first 8 hours to the final vol- |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| tage of 600 volts. The separated bands were collected as 2-ml |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| fractions through a Teflon capillary tubing from the bottom of |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| the column by gravity. The pH was determined for every frac- |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_continue
bodyText ||| tion. The pH gradient was always linear within the range of |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| the ampholyte. |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| Gel Filtration—The supernatant of the sonicated water homoge- |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
bodyText ||| nate used for electrofocusing was also used for fractionation of |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| 0-galactosidases by a column of (3 X 30 cm) of Sephadex G-200, |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| which had been pre-equilibrated with 10 mm sodium phosphate |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_continue
bodyText ||| buffer, pH 7.0. The same buffer was used for elution. The elu- |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| ates were collected as 4-ml fractions and were monitored by the |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| optical density at 280 nm. |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
subsectionHeader ||| Source of Chemicals |XML| xmlLoc_3 xmlBold_no xmlItalic_yes xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
bodyText ||| The following were the commercial sources of the chemicals |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
bodyText ||| used for this study: unlabeled galactosylceramide and 4-methyl- |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| umbelliferyl 13-galactoside, Koch-Light Laboratories, Colnbrook, |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| England; silicic acid for column chromatography (Union), Clark- |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_continue
bodyText ||| son Chemical Co., Williamsport, Pa.; galactose oxidase, Worth- |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| ington Biochemical Corp., Freehold, N. J.; sodium [311]borohy- |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| dride, 400 mCi per mmole, New England Nuclear Corp., Boston, |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_continue
bodyText ||| Mass.; Bio Solv BBS-3, Beckman Instruments, Fullerton, Calif.; |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| Cab-O-Sil, Packard Instrument Co., Downers Grove, Ill.; Myrj |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_continue
bodyText ||| 59 (polyoxyethylene stearate), Atlas Chemical Co., Wilmington, |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| Del.; carrier ampholyte (Ampholine), LKB Instruments, Rock- |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_continue
bodyText ||| ville, Md.; crude bovine brain ganglioside mixture, oleic acid, |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| Tween 80, Triton X-100, sodium taurocholate, and sodium etiolate, |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_continue
bodyText ||| Sigma Chemical Co., St. Louis, Mo. |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_continue
sectionHeader ||| RESULTS |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
bodyText ||| While properties of galactosylceramide 0-galactosidase were |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
bodyText ||| extensively studied (12, 16-18) and those of lactosylceramide |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| galactosidase were investigated in some detail previously (13, 20), |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| little is known about the other splaingolipid 0-galactosidases. In |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| order to establish the standard assay procedures, therefore, a |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| series of preliminary experiments was carried out to clarify some |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| of the kinetic properties of these enzymes. |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
subsectionHeader ||| Time Course of Reaction and Effect of Chloride Ion |XML| xmlLoc_6 xmlBold_no xmlItalic_yes xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
bodyText ||| When assays were performed for lactosylceramide, Gmi-gan- |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
bodyText ||| glioside and asialo Gmi-ganglioside ,3-galactosidases in the stan- |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| dard systems without added NaC1, the reaction was linear for |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| 120 min for only lactosylceramide (3-galactosidase. Linear reac- |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| tions could not be maintained for the other two enzymes, which |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| showed severe declines of the reaction rate during the 30 to 60 |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| min compared to the first 30 min (Fig. 1). The addition of so- |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| dium chloride ill the media had two effects on the reactions, |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| stimulation and stabilization. With the complete standard as- |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| say system, lactosylceramide 0-galactosidase was activated to |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| obtained without exogenous chloride ions in the assay systems. |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
bodyText ||| 0-0 shows the reactions in the complete assay systems with |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| 10 mm sodium chloride. The enzyme source was diluted 5X for |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| lactosylceramide (3-galactosidase and 50X for asialo i-ganglio- |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_continue
bodyText ||| side 0-galactosidase. |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
figure ||| I	I	I	I	I |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
figure ||| 0	5	10	15	20	25 |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
figure ||| CHLORIDE ON CONCENTRATION, rnM |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
figureCaption ||| FIG. 2. Effect of chloride ion concentration. Activities of |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
figureCaption ||| lactosylceramide (/), asialo i-ganglioside (//), and Gml-gan- |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_continue
figureCaption ||| glioside (III) 0-galactosidases were assayed according to the |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
figureCaption ||| standard assay procedures described in the text, except that the |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_continue
figureCaption ||| concentration of the chloride ion in the system was varied as indi- |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
figureCaption ||| cated. The enzyme source was diluted 5X for lactosylceramide |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
figureCaption ||| 0-galactosidase, and 100X for asialo Gm i-ganglioside g-galactosid- |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_continue
figureCaption ||| ase. The incubation time was 60 min. |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_continue
bodyText ||| 170% of the activity obtained in the chloride-free system, still |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
bodyText ||| maintaining the linear reaction for at least 120 min. The in- |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_continue
bodyText ||| crease in the reaction rate by chloride was less marked for the |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| other two (3-galactosidases but the reaction became more stable |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| in the presence of chloride. At the 10 IT1M final concentration, |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| the reactions were nearly linear for the first 60 min, although the |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_continue
bodyText ||| decline in the reaction rates was still considerable after this period |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_continue
bodyText ||| (Fig. 1). The effects of chloride ion reached the maximum at the |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| final concentration of 10 mm and remained unchanged at least |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| up to 30 mm (Fig. 2). These findings on the effects of chloride |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| on the activities of specific glycosphingolipid (3-galactosidases are |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| similar to those reported by Ho and O'Brien on nonspecific 4- |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| methy lumbelliferyl $-galactosidase (21). |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
subsectionHeader ||| Effect of pH and Substrate Concentration |XML| xmlLoc_6 xmlBold_no xmlItalic_yes xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
bodyText ||| The pH optima for lactosylceramide and asialo Gml-gangli- |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
bodyText ||| oside /3-galactosidases were 4.8, while that of Gml-ganglioside |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| /3-galactosidase was 4.4, essentially the same as the pH optimum |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| of galactosylceramide 0-galactosidase (Fig. 3). Approximately |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| 50 ,ttg of substrates were required to saturate the enzymes in the |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| respective assay systems, and no substrate inhibition was ob- |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| served up to 150 1.ig (Fig. 4). |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
subsectionHeader ||| Effect of Detergents |XML| xmlLoc_7 xmlBold_no xmlItalic_yes xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
bodyText ||| Taurocholate is known to be the most effective activator for |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
bodyText ||| galactosylceramide and lactosylceramide 0-galactosidases (13, |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
figure ||| 6 |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
figure ||| i |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
figure ||| —2 x |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
figure ||| .2_ |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
figure ||| 0 |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
figure ||| —1 IV |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
figure ||| 0 |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
figure ||| 30 |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
figure ||| 3.0 |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
figure ||| 4.0 |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
figure ||| 5.0 |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
figure ||| pH |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
figure ||| 6.0 |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
figure ||| 100 |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
figure ||| 20 |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
figure ||| to	.52 10—	7	10 |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_yes xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
figure ||| ...-	r	v.) |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
figure ||| el	A ....• |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
figure ||| S.	I 	=110 |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
figure ||| ...,	.r.	........- -----* |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
figure ||| /x |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
figure ||| J•/' |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
figure ||| -	i://c... |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
figure ||| 0	u.,	82 |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
figure ||| &lt; |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
figure ||| /1 |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
figure ||| 11 5	— //	-	5 d	0 5 |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
figure ||| pc	cg |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
figure ||| “.1	Ii |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
figure ||| P_	4 |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
figure ||| y |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
figure ||| 25 |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
figure ||| 6	I	I |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
figure ||| 0 20	50	100	150 |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
figure ||| AMOUNT OF SUBSTRATE, p.g/incubation |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
figure ||| 2101 |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
figure ||| 30 |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
figureCaption ||| FIG. 3 (left). Effect of pH. Activities of lactosylceramide (/), |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
figureCaption ||| asialo Gml-ganglioside (//), and Gm i-ganglioside (///)13-galacto- |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
figureCaption ||| sidases were assayed according to the standard assay procedures |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
figureCaption ||| described in the text, except that the standard citrate buffer was |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
figureCaption ||| replaced with citrate buffers of varying pH. The results are ex- |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
figureCaption ||| pressed in relative activities with the optimal activities as 100 for |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
figureCaption ||| respective reactions. |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
figureCaption ||| FIG. 4 (center). Effect of substrate concentration. Activities |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
figureCaption ||| of lactosylceramide (I), asialo Gm 1-ganglioside (//), and Gmi- |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
figureCaption ||| ganglioside (///) 0-galactosidases were assayed according to the |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
figureCaption ||| standard assay procedures as described in the text, except the |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
figureCaption ||| amounts of the substrates were varied as indicated. The enzyme |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| 18). For hydrolysis of asialo GI-ganglioside, sodium tauro- |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
bodyText ||| cholate was also the most effective activator, while little activities |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| were observed when taurocholate was replaced by cholate, Tween |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| 80, or Triton X-100 (Fig. 5). The maximum reaction was ob- |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| tained at the taurocholate concentration of 2.5 mg per ml, and |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| this concentration was adopted for the standard assay system. |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| In contrast, none of these detergents appeared to affect the |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| activity of Gml-ganglioside 0-galactosidase and, therefore, no de- |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| tergent was included in the assay system for this enzyme. |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
subsectionHeader ||| Fractionation of Glycosphingolipid #-Galactosidases |XML| xmlLoc_4 xmlBold_no xmlItalic_yes xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
bodyText ||| Electrofocusing (Fig. 6)—Two adult liver specimens, ages 30 |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
bodyText ||| and 47 years old, were studied. The electrofocusing procedure |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| separated 4-methylumbelliferyl 13-galactosidase activities into |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| three fractions, which are tentatively designated as a, fl, and -y |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| in the order of increasing isoelectric points. The respective iso- |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| electric points were pH 4.1 to 4.2 for a, pH 4.5 to 4.6 for and |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| pH 4.8 to 4.9 for 7. These peaks were consistently observed not |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| only in the two specimens, but in several additional normal liver |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| specimens. There were three activity peaks for both lactosy 1- |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| ceramide and asialo Gml-ganglioside 0-galactosidases, correspond- |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| ing in isoelectric points to the three peaks of 4-methylumbelliferyl |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| #-galactosidase. In contrast, both galactosylceramide and Gm 1- |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| ganglioside 0-galactosidases gave only two peaks of activity |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| corresponding to the )3 and 7 peaks. These findings were identi- |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| cal in the two specimens studied. |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| Gel Filtration (Fig. 7)—As in electrofocusing, three peaks of |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
bodyText ||| 4-methylumbelliferyl $-galactosidase activities were observed by |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| Sephadex G-200 gel filtration. These are designated as Peaks I, |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| II, and III in the order of decreasing molecular sizes. The recov- |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| ery of the total activity applied on the column was essentially |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| quantitative. Peak I contained activities of galactosylceramide, |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| lactosylceramide and asialo Gm 1-ganglioside 0-galactosidases. |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| Peak II showed activities of lactosylceramide and asialo Gm 1- |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| source was diluted 10X for lactosylceramide and asialo Gml-gan- |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
bodyText ||| glioside 0-galactosidases, and the incubation time was 30 min for |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| asialo Gmi-ganglioside P-galactosidase and 60 min for the others. |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| FIG. 5 (right). Effect of detergents on asialo Gmi-ganglioside |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
bodyText ||| I3-galactosidase. Activities of the enzyme source (10X dilution) |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| were assayed according to the standard assay procedure as de- |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| scribed in the text except that detergents were varied as indicated. |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| In all experiments, the concentration of the detergents was 1 mg |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| per incubation. 0- - -0, standard system (taurocholate); |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| • • , standard system minus NaCl; sodium cholate; |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| A -A, Tween 80; 0- - -0, Triton X-100. |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
bodyText ||| ganglioside 0-galactosidases but lacked the activity of galactosyl- |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
bodyText ||| ceramide )3-galactosidase. Peak III was not associated with any |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| of the above three lipid 0-galactosidases. Because of the rela- |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| tively low activity and the large dilution after gel filtration, Gm,- |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| ganglioside 13-galactosidase could not be measured reliably on |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| these fractions. |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| The three peaks of 4-methylumbelliferyl )3-galactosidase ac- |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
bodyText ||| tivity separated by gel filtration were pooled separately, and each |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| fraction was subjected to electrofocusing. The gel filtration |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| Peak II gave a single band in electrofocusing with an isoelectric |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| point of 4.5 to 4.6 (0 peak). Peak III corresponded to the -y |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| peak (pH 4.8 to 4.9) in electrofocusing. However, the finding on |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| the gel filtration Peak I was complex and inconclusive. Although |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| the Peak I fraction always gave a single electrofocusing peak, its |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| isoelectric point was variable from one gel filtration run to an- |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| other and usually did not correspond to any of the normal a, |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| (3, and -y peaks |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
sectionHeader ||| DISCUSSION |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
bodyText ||| Unnatural synthetic substrates, such as p-nitrophenyl or |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
bodyText ||| 4-methylumbelliferyl glycosides, are commonly used in studies of |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| glycosidases. While this approach offers practical advantage of |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| simplicity, there is an inherent limitation in the use of unnatural |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| substrates when detailed studies of specific glycosidases are in- |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| tended. There are at least three genetically distinct sphingo- |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| lipidoses in which specific sphingolipid i3-galactosidases are de- |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| ficient: globoid cell leukod;ystrophy (2), lactosylceramidosis (3), |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| and Gml-gangliosidosis (5). The use of natural substrates would |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| be highly desirable for the study of the mutant enzymes in these |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| disorders. |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| The choice of the enzyme source for this study was dictated by |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
bodyText ||| the purpose of the subsequent studies on the tissue of patients |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| with genetic sphingolipidoses and represents a pragmatic com- |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| promise. The use of the low, speed supernatant for studies of |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
page ||| 2102 |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
figure ||| 4 0	4 5	50 |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
figure ||| ISOELECTRIC POINT, pH |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
figureCaption ||| FIG. 6. Electrofocusing patterns of 0-galactosidases. The en- |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
figureCaption ||| zyme source prepared as described in the text from 30-year-old |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
figureCaption ||| normal human liver was fractionated by electrofocusing in 1% |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
figureCaption ||| ampholyte, pH 4 to 6. Two-milliliter fractions were collected, |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
figureCaption ||| and 0.1-ml aliquots were used for enzyme assays. pH was deter- |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
figureCaption ||| mined for all tubes. Results are expressed as relative activities |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
figureCaption ||| with the highest activities of respective enzymes as 100. A, 4- |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
figureCaption ||| methylumbelliferyl fl-galactosidase; B, galactosylceramide 13-ga- |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
figureCaption ||| lactosidase; C, lactosylceramide 0-galactosidase; D, asialo Gml- |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
figureCaption ||| ganglioside 13-galactosidase; E, Gml-ganglioside ti-galactosidase. |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| enzymes always carries the risk of unknown influence by other |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
bodyText ||| tissue components present in the preparation. From the stand- |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| point of basic enzymology, it would have been desirable to use |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| at least the 100,000 x g supernatant, if not a further purified |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_continue
bodyText ||| preparation, for characterization. However, when the purpose |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| of the study is aimed at genetic enzymatic abnormalities, the use |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| of purified preparations carries its own risk. It is not known in |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| which way the enzyme is abnormal in the pathological tissue. It |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| may not only be abnormal in the total activity, but also in solubil- |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| ity, subcellular distribution, isozyme patterns, etc. Due to the |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| very nature of the enzyme purification procedures, a substantial |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| portion of the total activity in the starting tissue is usually elimi- |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| nated from the final clean preparation. The crucial abnormali- |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| ties might be present in fractions eliminated during purification. |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| For assessing the total enzymatic activity in the tissue, very crude |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| preparations must be used because we cannot assume even the |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| same recovery of the total activity in the final purified prepara- |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| tions from normal and pathological tissues. A high recovery and |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| good operational reproducibility become the most important |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| criteria for the purpose of our subsequent studies of disorders. |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| Our aim in this study was to find procedures which permit us to |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| handle relatively crude preparations and obtain reproducible re- |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| sults from normal tissues so that results from pathological tissues |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| can be confidently compared. The standard assay procedures |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| and the electrofocusing procedure described in this report satisfy |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
figure ||| 20	30	40 |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
figure ||| TUBE NUMBER |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
figureCaption ||| FIG. 7. Gel filtration patterns of p-galactosidases. The en- |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
figureCaption ||| zyme source was the same as in Fig. 6. Fractionation was on a |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
figureCaption ||| column (3 X 30 cm) of Sephadex G-200 eluted with 10 mm sodium |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
figureCaption ||| phosphate buffer, pH 7.0, as 4-ml fractions. Enzyme activities |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
figureCaption ||| were assayed on 0.1-ml aliquots. The results are expressed as |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
figureCaption ||| relative activities with the highest activities of respective enzymes |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
figureCaption ||| as 100. A, 4-methylumbelliferyl 0-galactosidase; B, galactosyl- |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
figureCaption ||| ceramide (3-galactosidase; C, lactosylceramide 0-galactosidase; |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
figureCaption ||| D, asialo 1-ganglioside 0-galactosidase. The emergence of |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
figureCaption ||| Peak I coincides with the void volume of the column, and the |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
figureCaption ||| total column volume was 212 ml. |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| these criteria. Our results are, therefore, to a considerable de- |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
bodyText ||| gree, operationally defined and should be viewed with appropriate |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| caution. |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| The first phase of the present study was carried out in order to |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
bodyText ||| determine the optimal conditions of assays for some of the glyco- |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_continue
bodyText ||| sphingolipid #-galactosidases, which have not been extensively |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| investigated. As Ho and O'Brien have observed with synthetic |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| substrates (21), chloride ion has both activating and stabilizing |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| effect on sphingolipid 13-galactosidases. Without the added |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| chloride, for example, the activity of asialo Gm i-ganglioside 0- |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| galactosidase could not be maintained beyond 15 min of incuba- |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| tion, while the presence of 10 mm NaCl restored the reasonably |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| linear reaction up to 60 min. |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| 0-Galactosidase has been separated into subcomponents by |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
bodyText ||| several separation techniques. Two or three fractions were sep- |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| arated by electrophoresis or gel filtration in Trichomonas foetus |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| (22), rat kidney (23), ox liver (24), rabbit and monkey brain (25), |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| monkey small intestine (26), hog small intestine (27), human liver |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| (28-31), human intestine (32, 33), and in other human organs |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| and cultured fibroblasts (34). In rat kidney, four 0-galactosidase |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| peaks were found by DEAE-cellulose column chromatography |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| (35). In Escherichia coil, Marchesi et al. (36) separated 10 bands |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| with 0-galactosidase activity by polyacrylamide disc gel electro- |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| phoresis, and six well defined sedimentation zones by analytical |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| ultracentrifugation. These fractions consisted of a tetramer |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| molecule (the major fraction) and its aggregates (heavy iso- |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| zymes). Most of these fractionation studies used synthetic sub- |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| strates, although lactose and other oligosaccharides were used as |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
table ||| 100 |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
table ||| 50 |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
table ||| 2103 |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
tableCaption ||| TABLE I |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
tableCaption ||| Relationship between human hepatic 13-galactosidase |XML| xmlLoc_0 xmlBold_no xmlItalic_yes xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
tableCaption ||| fractions separated by gel filtration and those |XML| xmlLoc_0 xmlBold_no xmlItalic_yes xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
tableCaption ||| separated by other separation procedures |XML| xmlLoc_0 xmlBold_no xmlItalic_yes xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
table ||| Other procedures	Gel filtration	Reference |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
table ||| Peak	Peak 	Peak |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
table ||| II	III |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
table ||| Electrofocusing and |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
table ||| kinetic study"	A + B	A	Hultberg et al. |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
table ||| Electrophoresis"	A + C	A	Ho and O'Brien |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
table ||| Electrofocusing	Not	Present study |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
table ||| con- |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
table ||| sist- |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
table ||| ent |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_no xmlTable_yes xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
tableCaption ||| "Designations of A, B, and C by Hultberg et al, (30) and Ho |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
tableCaption ||| and O'Brien (31) are mutually independent. |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| natural substrates for the studies of intestinal 0-galactosidases |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
bodyText ||| (26, 27, 32, 33) and, in a few instances, natural sphingoglycolipids |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| (25, 30). |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| The purpose of the second phase of this study was 2-fold: (a) |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
bodyText ||| to separate nonspecific 0-galactosidase activities in human liver |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| by the gel filtration and electrofocusing techniques, and (b) to |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| investigate the hydrolytic activities of the separated components |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| on natural sphingolipid substrates. Ockerman (28), Hultberg |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| and Ockerman (29), and Hultberg et al. (30), separated human |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| liver 0-galactosidase into three fractions by gel filtration: Peaks |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| I, II, and III in the order of elution. Based on kinetic and elec- |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| trofocusing studies of these peaks, they concluded that these three |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| peaks consist of two enzymes, Enzymes A and B, and that Peak I |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| contains both Enzymes A and B, Peak II only Enzyme B, and |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| Peak III only Enzyme A. On the other hand, Ho and O'Brien |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| (31) also separated three fractions of human liver 13-galactosidase |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| by gel filtration. When these fractions were subjected to starch |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| gel electrophoresis, Peak I corresponded to Spot B on the electro- |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| phoretogram, Peak II to Spots A and C, and Peak III to Spot A.' |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| Our findings on nonspecific fl-galactosidase separated by gel fil- |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| tration were similar to these previous studies, giving three well |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| defined activity peaks. Apparent 1:1 correspondence between |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| Peak II of gel filtration and the 13 peak of electrofocusing, and |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| between Peak III and the 7 peak was observed. The results |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| of these three series of studies, summarized in Table I, indicate |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| the highly complex nature of the 0-galactosidase components. |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| We were unable to obtain consistent results in electrofocusing |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
bodyText ||| characterization of the first gel filtration peak (I) of 0-galac- |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| tosidase. Even from a single liver specimen, the separated Peak |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| I from different gel filtration runs gave electrofocusing peaks of |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| apparently different isoelectric points, although it always gave a |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| single electrofocusing peak. The complex nature of Peak I has |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| also been observed by other investigators previously. Hultberg |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| and Ockerman (29) observed two peaks, I and II, when they re- |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| chromatographed the isolated Peak I fraction on Sephadex |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| G-150. Gray and Santiago (32) obtained three 0-galactosidase |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| fractions of human intestine from Bio-Gel P-300 column. Upon |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| density gradient ultracentrifugation, they found that each of the |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| two peaks of lower molecular weights corresponded to one of the |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
note ||| The nomenclatures of Enzymes A and B by Hultberg et al. (30) |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
note ||| and that of Spots A, B, and C by Ho and O'Brien (31) are mutually |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
note ||| independent. Enzymes A and B in the former do not necessarily |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
note ||| correspond to Spots A and B on starch gel electrophoresis. |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
tableCaption ||| TABLE II |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
tableCaption ||| Human hepatic O-galactosidases separated by |XML| xmlLoc_0 xmlBold_no xmlItalic_yes xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_continue
tableCaption ||| electrofocusing and gel filtration |XML| xmlLoc_0 xmlBold_no xmlItalic_yes xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
tableCaption ||| " N.D., not determined. |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
bodyText ||| two discrete sedimentation bands. However, the peak of /3-ga- |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
bodyText ||| lactosidase activity eluted at the void volume gave a much |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| heavier fraction, in addition to one of the above two fractions. |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| Such a heavy fraction was not obtained when the enzyme source |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| was subjected to density gradient centrifugation directly without |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| prior separation by gel filtration. These findings suggested to the |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| authors that aggregation or fragmentation of enzyme molecules |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| occurred during the analytical manipulations. It is also known |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| that the major tetrameric molecule of E. coli (3-galactosidase can |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| be dissociated under various conditions eventually to the mono- |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| meric form with concomitant loss of activity (36-38). The |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| inconsistent behavior of gel filtration Peak I of human liver i3-ga- |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| lactosidase, therefore, may be the result of aggregation or disso- |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| ciation phenomena, or both, during the course of the fractionation |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| procedures. In addition, possible interaction between the en- |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| zyme protein and other tissue components might also have to be |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| kept in mind as a possible explanation since our preparations are |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| crude. |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| The main purpose of our present study was to investigate the |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
bodyText ||| hydrolytic activities of each fraction against the natural sphingo- |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| lipid substrates. Here, the only previous report with which we |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| can compare our results is that of Hultberg et al. (30). They used |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| galactosylceramide, lactosylceramide, and transferrin glycopep- |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| tide as the natural substrates. Upon electrofocusing, they ob- |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| served that the peaks at pH 4.2 to 4.3 and pH 4.9 to 5.0 (a and 7) |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| hydrolyzed the natural substrates, but the peak at pH 4.5 to 4.6 |XML| xmlLoc_5 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| (13) had no enzymatic activity toward them. Our data differ |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| considerably from theirs. In our hands, the and 7 peaks hy- |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| drolyzed the terminal galactose from all of the four glycosphingo- |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| lipids, while the a peak was active only toward lactosylceramide |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| and asialo Gm i-ganglioside and was inactive toward galactosyl- |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| ceramide and Gm i-ganglioside. These discrepancies may well |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| be due to the difference in the starting enzyme source. Hultberg |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| et al. (30) used the high speed supernatant while our enzyme |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| source was a low speed supernatant. Our results with the gel |XML| xmlLoc_6 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| filtration fractions agree better with those of Hultberg et al. (30) |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| except that, in our hands, Peak II did not hydrolyze galactosyl- |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| ceramide. The distribution of (3-galactosidase activities toward |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| natural sphingolipid substrates among the gel filtration and elec- |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| trofocusing fractions clearly indicate the highly complex nature |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| of these fractions. No simple relationship exists between the |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| fractions separated by electrofocusing and those by gel filtration. |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| The information gathered in the present study is summarized |XML| xmlLoc_7 xmlBold_no xmlItalic_no xmlFontSize_common xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
figure ||| 4-Methyl- |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
figure ||| umbel- |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
figure ||| Meryl |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
figure ||| fl-galac- |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
figure ||| tosidase |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
figure ||| Components |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
figure ||| Gm t- |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
figure ||| gang lio- |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
figure ||| side |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
figure ||| Ga facto- |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
figure ||| sylcera - |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
figure ||| mide |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
figure ||| Lactosyl- |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
figure ||| ceramide |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
figure ||| Asialo |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
figure ||| Gm 1- |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
figure ||| ganglio- |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
figure ||| side |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
figure ||| Substrates |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
figure ||| Electrofocusing |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
figure ||| peaks |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
figure ||| a (pH 4.1-4.2) |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
figure ||| # (pH 4.5-4.6) |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
figure ||| y (pH 4.8-4.9) |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
figure ||| Gel filtration peaks |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
figure ||| II, |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
figure ||| III. |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
figure ||| +	+	+	+ |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
figure ||| +	-	+	+ |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
figure ||| +	- |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
figure ||| - |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
figure ||| N.D.G |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
figure ||| N.D. |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
figure ||| N.D. |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
page ||| 2104 |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
bodyText ||| in Table II and will serve as the base-line data for our subsequent |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
bodyText ||| investigations on globoid cell leukodystrophy and Gm1-gangli- |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| osidosis, which are characterized by genetic deficiencies of specific |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| 0-galactosidases. The results of these studies are presented in |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
bodyText ||| the accompanying articles (39-41). |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
sectionHeader ||| REFERENCES |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
reference ||| 1. STANBuRY, J. B., WYNGAARDEN, J. B., AND FREDERICKSON, |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_new bi_xmlPara_new
reference ||| D. S., eds (1972) Metabolic Basis of Inherited Disease, pp. |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
reference ||| 615-807, McGraw-Hill Book Co., New York	25. |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
reference ||| 2. Suzuki, K., AND SUZUKI, Y. (1970) Proc. Nat. Acad. Sci. |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_new
reference ||| U. S. A. 66, 302-309	26. |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_new bi_xmlPara_continue
reference ||| 3. DAWSON, G., AND STEIN, A. 0. (1970) Science 170, 556-558 |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_new bi_xmlPara_new
reference ||| 4. Kimr, J. A. (1970) Science 167, 1268-1269	27. |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_new
reference ||| 5. OKADA, S., AND O'BRIEN, J. S. (1968) Science 160, 1002-1004 28. |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_new
reference ||| 6. SANDHOFF, K. (1969) Fed. Eur. Biochem. Soc. Lett. 4, 351-354	29. |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_new bi_xmlPara_new
reference ||| 7. OKADA, S., AND O'BRIEN, J. S. (1969) Science 165, 698-700 |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_new bi_xmlPara_new
reference ||| 8. Suzuki, Y., AND SUZUKI, K. (1970) Neurology 20, 848-851	30. |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_new
reference ||| 9. AUSTIN, J., ARMSTRONG, D., AND SHEARER, L. (1965) Arch. |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_new bi_xmlPara_new
reference ||| Neurol. 13, 593-614	31. |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
reference ||| 10. FOLCH, J., LEES, M., AND SLOANE-STANLEY, G. H. (1957) J. |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_new
reference ||| Biol. Chem. 226, 497-509	32, |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
reference ||| 11. NORTON, W. T., AND Aumnio, L. A. (1965) Ann. N. Y. Acad. |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_new
reference ||| Sci. 122, 77-85	33. |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
reference ||| 12. HAJRA, A. K., BOWEN, D. M., KISHIMOTO, Y., AND RADIN, 34. |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_new
reference ||| N. S. (1966) J. Lipid Res. 7, 379-386 |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
reference ||| 13. RADIN, N. S., Hop, L., BRADLEY, R. M., AND BRADY, R. 0. 35. |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_new
reference ||| (1969) Brain Res. 14, 497-505 |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
reference ||| 14. SUZUKI, K., AND CHEN, G. C. (1967) J. Lipid Res. 8, 105-113 36. |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_new
reference ||| 15. Suzuki, Y., AND SUZUKI, K. (1972) J. Lipid Res. 13, 687-690 |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_new
reference ||| 16. BOWEN, D. M., AND RADIN, N. S. (1969) J. Neurochem. 16, 501— 37. |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_new
reference ||| 511 |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
reference ||| 17. BOWEN, D. M., AND RADIN, N. S. (1968) Biochim. Biophys. 38. |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_new
reference ||| Acta 152, 587-598 |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_continue bi_xmlPara_continue
reference ||| 18. BOWEN, D. M., AND RADIN, N. S. (1968) Biochim. Biophys. 39. |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_new bi_xmlPara_new
reference ||| Acta 152, 599-610 |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_yes bi_xmlSFBIA_new bi_xmlPara_continue
reference ||| 19. SUZUKI, K., SUZUKI, Y., AND ETO, Y. (1971) in Lipid Storage 40. |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
reference ||| Diseases: Enzymatic Defects and Clinical Implications |XML| xmlLoc_4 xmlBold_no xmlItalic_yes xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_continue
reference ||| (BERNSOHN, J., AND GROSSMAN, H. J., eds) pp. 111-136, 41. |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_continue
reference ||| Academic Press, New York |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
reference ||| GATT, S., AND RAPPORT, M. M. (1966) Biochem. J. 101, 680— |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
reference ||| 686 |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
reference ||| Ho, M. W., AND O'BRIEN, J. S. (1970) Clin. Chim. Acta 30, |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
reference ||| 531-534 |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
reference ||| HARRAP, G. J., AND WATKINS, W. M. (1970) Biochem. J. 117, |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
reference ||| 667-675 |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
reference ||| RomNsoN, D., PRICE, R. G., AND DANCE, N. (1967) Biochem. |XML| xmlLoc_0 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
reference ||| J. 102, 525-532 |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
reference ||| CHYTIL, F. (1965) Biochem. Biophys. Res. Commun. 19, 630— |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
reference ||| 636 |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_continue
reference ||| JUNGALWALA, F. B., AND ROBINS, E. (1968) J. Biol. Chem. 243, |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
reference ||| 4258-4266 |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
reference ||| SWAMINATHAN, N., AND RADHAKRISHNAN, A. N. (1969) Arch. |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
reference ||| Biochem. Biophys. 135, 188-295 |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_continue
reference ||| SATO, M., AND YAMASHINA, I. (1971) J. Biochem. 70, 683-692 |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
reference ||| OCKERMAN, P.-A. (1968) Biochim. Biophys Acta 165, 59-62 |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_continue
reference ||| HULTBERG, B., AND OCKERMAN, P.-A. (1969) Scand. J. Clin. |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
reference ||| Lab. Invest. 23, 213-217 |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
reference ||| HULTBERG, B., OCKERMAN, P.-A., AND DAHLQVIST, A. (1970) |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
reference ||| J. Clin. Invest. 49, 216-224 |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_continue
reference ||| Ho, M. W., AND O'BRIEN, J. S. (1971) Clin. Chim. Acta 32, |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
reference ||| 443-450 |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
reference ||| GRAY, G. M., AND SANTIAGO, N. A. (1969) J. Clin. Invest. 48, |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
reference ||| 716-728 |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
reference ||| ASP, N.-G. (1971) Bioc hem. J. 121, 299-308 |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
reference ||| FLUHARTY, A. L., LASSILA, E. L., PORTER, M. T., AND KIHARA, |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
reference ||| H. (1971) Biochem. Med. 5, 158-164 |XML| xmlLoc_2 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
reference ||| PATEL, V., AND TAPPEL, A. L. (1970) Biochim. Biophys. Acta |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
reference ||| 220, 622-624 |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
reference ||| MARCHESI, S. L., STEERS, E., JR., AND SHIFRIN, S. (1969) Bio- |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
reference ||| chim. Biophys. Acta 181, 20-34 |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_continue
reference ||| SHIFRIN, S., LUBORSKY, S. W., AND GROCHOWSKI, B. J. (1970) |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
reference ||| Biochem. Biophys. Res. Commun. 39, 997-1002 |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_continue
reference ||| WicksoN, V. M., AND HUBER, R. E. (1970) Biochim. Biophys. |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
reference ||| Acta 207, 150-155 |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
reference ||| Suzuki, Y., AND SUZUKI, K. (1974) J. Biol. Chem. 249, 2105— |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_new
reference ||| 2108 |XML| xmlLoc_3 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
reference ||| SUZUKI, Y., MIYATAKE, T., FLETCHER, T. F., AND SUZUKI, K. |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
reference ||| (1974) J. Biol. Chem. 249, 2109-2112 |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
reference ||| Suzuki, Y., AND SUZUKI, K. (1974) J. Biol. Chem. 249, 2113— |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_new
reference ||| 2117 |XML| xmlLoc_4 xmlBold_no xmlItalic_no xmlFontSize_smaller xmlPic_no xmlTable_no xmlBullet_no bi_xmlSFBIA_continue bi_xmlPara_continue
reference ||| 24. |XML| xmlLoc_1 xmlBold_no xmlItalic_no xmlFontSize_none xmlPic_yes xmlTable_no xmlBullet_no bi_xmlSFBIA_new bi_xmlPara_continue

